Argenx
ARGX
#495
Rank
A$70.52 B
Marketcap
A$1,129
Share price
0.81%
Change (1 day)
25.54%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): A$23.66

According to Argenx 's latest financial reports the company's current EPS (TTM) is A$22.18. In 2024 the company made an earnings per share (EPS) of A$19.53 an increase over its 2023 EPS that were of A-$7.24.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$23.66
2024A$19.53-369.77%
2023A-$7.24-60.46%
2022A-$18.3163.33%
2021A-$11.21-40.37%
2020A-$18.80183.47%
2019A-$6.63123.09%
2018A-$2.9754.93%
2017A-$1.9214.07%
2016A-$1.6813.05%
2015A-$1.49-36.34%
2014A-$2.34209.04%
2013A-$0.76-33.99%
2012A-$1.15185.59%
2011A-$0.40